BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND RUNX1T1, ENSG00000079102, 862 AND Diagnosis
28 results:

  • 1. Assessment of whole-body MRI including diffusion-weighted sequences in the initial staging of breast cancer patients at high risk of metastases in comparison with PET-CT: a prospective cohort study.
    Hottat NA; Badr DA; Ben Ghanem M; Besse-Hammer T; Lecomte SM; Vansteelandt C; Lecomte SL; Khaled C; De Grove V; Salem Wehbe G; Cannie MM; Jani JC
    Eur Radiol; 2024 Jan; 34(1):165-178. PubMed ID: 37555959
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [The clinical value of serum GPC3 level in predicting recurrence of patients with primary hepatocellular carcinoma].
    Zhang PR; Ma XL; Guo L; Lu RQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jun; 57(6):885-890. PubMed ID: 37357208
    [No Abstract]    [Full Text] [Related]  

  • 3. Comparison of diagnostic performance of AFP, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study.
    Chen Y; Yang X; Shao Y; Zhao H; Jiang J; Huang P; Lu Y; Xuan Z
    Ann Hepatol; 2023; 28(4):101099. PubMed ID: 37030571
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma.
    Yang Q; Ye H; Sun G; Wang K; Dai L; Qiu C; Shi J; Zhu J; Wang X; Wang P
    Mol Oncol; 2023 May; 17(5):887-900. PubMed ID: 36587394
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circulating microRNAs (miR-16, miR-22, miR-122) expression and early diagnosis of hepatocellular carcinoma.
    Fang Y; Yan D; Wang L; Zhang J; He Q
    J Clin Lab Anal; 2022 Jul; 36(7):e24541. PubMed ID: 35666610
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Nomogram Predicts Risk and Prognostic Factors for Bone Metastasis of Pancreatic cancer: A Population-Based Analysis.
    Zhang W; Ji L; Wang X; Zhu S; Luo J; Zhang Y; Tong Y; Feng F; Kang Y; Bi Q
    Front Endocrinol (Lausanne); 2021; 12():752176. PubMed ID: 35356148
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Validity of initial cancer diagnoses in the diagnosis Procedure Combination data in Japan.
    Shigemi D; Morishima T; Yamana H; Yasunaga H; Miyashiro I
    Cancer Epidemiol; 2021 Oct; 74():102016. PubMed ID: 34450452
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
    Toy M; Hutton D; Harris AM; Nelson N; Salomon JA; So S
    Clin Infect Dis; 2022 Jan; 74(2):210-217. PubMed ID: 33956937
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical Significance and Role of TK1, CEA, CA 19-9 and CA 72-4 levels in diagnosis of Colorectal cancers.
    Singh S; Kumar R; Kumar U; Kumari R
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3133-3136. PubMed ID: 33247667
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
    Jiang H; Song B; Qin Y; Chen J; Xiao D; Ha HI; Liu X; Oloruntoba-Sanders O; Erkanli A; Muir AJ; Bashir MR
    Eur Radiol; 2021 Jun; 31(6):3638-3648. PubMed ID: 33245494
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Evaluation of serum AFP and DCP levels in the diagnosis of early-stage HBV-related HCC under different backgrounds.
    Song T; Wang L; Xin R; Zhang L; Tian Y
    J Int Med Res; 2020 Oct; 48(10):300060520969087. PubMed ID: 33135527
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Unsatisfactory Long-term Results of liver Transplant in Patients With Intrahepatic Cholangiocarcinoma.
    Krasnodębski M; Grąt M; Jastrzębski M; Szczęśniak M; Morawski M; Zając K; Patkowski W; Zieniewicz K
    Transplant Proc; 2020 Oct; 52(8):2463-2467. PubMed ID: 32327261
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Deep learning assisted differentiation of hepatocellular carcinoma from focal liver lesions: choice of four-phase and three-phase CT imaging protocol.
    Shi W; Kuang S; Cao S; Hu B; Xie S; Chen S; Chen Y; Gao D; Chen Y; Zhu Y; Zhang H; Liu H; Ye M; Sirlin CB; Wang J
    Abdom Radiol (NY); 2020 Sep; 45(9):2688-2697. PubMed ID: 32232524
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. diagnosis of vascular invasion in pancreatic ductal adenocarcinoma using endoscopic ultrasound elastography.
    Yamada K; Kawashima H; Ohno E; Ishikawa T; Tanaka H; Nakamura M; Miyahara R; Ishigami M; Hirooka Y; Fujishiro M
    BMC Gastroenterol; 2020 Mar; 20(1):81. PubMed ID: 32228472
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diagnostic Value of Serum Biomarkers in Combined Hepatocelluar-Cholangiocarcinoma.
    Chen J; Li Y; Yu G
    J Coll Physicians Surg Pak; 2020 Mar; 30(3):263-267. PubMed ID: 32169133
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Combination of inflammatory score/liver function and AFP improves the diagnostic accuracy of HBV-related hepatocellular carcinoma.
    Ding Y; Liu K; Xu Y; Zhao Q; Lou S; Xiang X; Yan L; Cao Z; Xie Q; Zhu C; Bao S; Wang H
    Cancer Med; 2020 May; 9(9):3057-3069. PubMed ID: 32150664
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Efficacy and Safety of Percutaneous Argon-Helium Cryoablation for Hepatocellular Carcinoma Abutting the Diaphragm.
    Yang Y; Zhang Y; Wu Y; Chen J; Liang B; Chen Q; Wang Q; Lyu J; Li Y; Mu F; Du D
    J Vasc Interv Radiol; 2020 Mar; 31(3):393-400.e1. PubMed ID: 31987705
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Dramatically changed immune-related molecules as early diagnostic biomarkers of non-small cell lung cancer.
    Ye X; Zhang N; Jin Y; Xu B; Guo C; Wang X; Su Y; Yang Q; Song J; Yu W; Cheng P; Cheng L; Gong Y; Fu X; Sun H
    FEBS J; 2020 Feb; 287(4):783-799. PubMed ID: 31482685
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinicopathologic Features of Colorectal Polyps in Shahid Beheshti University of Medical Sciences (SBMU).
    Ahadi M; Kazemi Nejad B; Kishani Farahani Z; Mollasharifi T; Jamali E; Mohaghegh Shalmani H; Dehgan A; Saberi Afsharian M; Sadeghi A; Movafagh A; Boran R; Rakhshan A; Moradi A; Heidari MH; Moradi A
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1773-1780. PubMed ID: 31244299
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Plasma mSEPT9: A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma.
    Oussalah A; Rischer S; Bensenane M; Conroy G; Filhine-Tresarrieu P; Debard R; Forest-Tramoy D; Josse T; Reinicke D; Garcia M; Luc A; Baumann C; Ayav A; Laurent V; Hollenbach M; Ripoll C; Guéant-Rodriguez RM; Namour F; Zipprich A; Fleischhacker M; Bronowicki JP; Guéant JL
    EBioMedicine; 2018 Apr; 30():138-147. PubMed ID: 29627389
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.